ArticleBJUI compass2022

The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinoma.

Kai Ozaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.